Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:



Restrictions on Lawyer Ads Involving Drugs and Medical Devices Are Not Unconstitutional, Says Federal Court

The Fourth Circuit has found that a West Virginia state law restricting how attorneys can solicit clients in pharmaceutical and medical device cases does not violate the First Amendment. At ...


Building a resilient tech strategy: Data bias

In recent years, data-driven technologies have transformed the world around us, we have computers that can translate for us, facial recognition systems to unlock our phones and algorithms...


Building a resilient tech strategy: Joint ventures

Building a resilient tech strategy is crucial to keep on top of the game. Most businesses, if they are not using technology already are probably looking into ways of using it to stay ahead...


China's draft implementation rules on human genetic resources: potential changes on HGR Supervision?
Registered Content

The Ministry of Science and Technology of China has finally issued the draft of Implementation Rules for the Regulations of Human Genetic Resources Administration for public...


Long-awaited update of the French “Convention Unique” for clinical trials finally published

A new French template agreement for clinical trials (Convention Unique) was published on April 9, 2022. This new version was much awaited since the initial version, dated back to 2016, was...


FDA issues ambitious new draft guidance to promote clinical trial diversity

On April 14, the U.S. Food and Drug Administration (FDA) released a new draft guidance to industry for increasing racial and ethnic diversity in clinical trials. The draft...


FDA updates “cybersecurity in medical devices” guidance, seeks industry input

The U.S. Food and Drug Administration (FDA) issued updated draft guidance, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket...


Clinical trials in Spain: Takeaways from the new code of conduct (Part 1)

Last week we raised our hands to inform you about the Spanish Data Protection Authority’s approval of the "Code of Conduct on the processing of personal data in the field of...


FDA finalizes guidance on premarket pathways for combination products

Recently, the U.S. Food and Drug Administration’s (FDA’s) Office of Combination Products (OCP) published the final guidance “Principles of Premarket Pathways for...

Loading data